Page last updated: 2024-11-07

4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl: metabolite of polychlorinated biphenyl cpds [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,2',5,5'-tetrachloro-4,4'-bis(methylsulfonyl)biphenyl : An member of the class of biphenyls that is 2,2',5,5'-tetrachlorobiphenyl in which the 4 and 4' positions are substituted by methylsulfonyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID115069
CHEBI ID49809
MeSH IDM0129971

Synonyms (17)

Synonym
bmstbp
4,4'-bis([h]methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl
1UTR
CHEBI:49809
4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl
66640-68-4
2,2',5,5'-tetrachloro-4,4'-bis(methylsulfonyl)-1,1'-biphenyl
2,2',5,5'-tetrachloro-4,4'-bis(methylsulfonyl)biphenyl
DB08373
1,1'-biphenyl, 2,2',5,5'-tetrachloro-4,4'-bis(methylsulfonyl)-
rx2c8qlh24 ,
unii-rx2c8qlh24
DTXSID60216807
4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachloro-biphenyl
4,4'-bis((h)methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl
Q27097588
PD004458
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
sulfoneAn organosulfur compound having the structure RS(=O)2R (R =/= H).
biphenylsBenzenoid aromatic compounds containing two phenyl or substituted-phenyl groups which are joined together by a single bond.
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, UTEROGLOBINRattus norvegicus (Norway rat)Kd0.01000.01000.01000.0100AID977611
Chain B, UTEROGLOBINRattus norvegicus (Norway rat)Kd0.01000.01000.01000.0100AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB1995Nature structural biology, Nov, Volume: 2, Issue:11
Solution structure of a mammalian PCB-binding protein in complex with a PCB.
AID1811Experimentally measured binding affinity data derived from PDB1995Nature structural biology, Nov, Volume: 2, Issue:11
Solution structure of a mammalian PCB-binding protein in complex with a PCB.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (37.50)18.7374
1990's5 (62.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.17 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]